Efficient synthesis of (R)-6-benzyloxycarbonylamino-1-methyl-4-(3- methylbenzyl)hexahydro-1,4-diazepine. I

Chemical and Pharmaceutical Bulletin

Volumn 46, Issue 7, 1998, Pages 1160-1164

  Harada, Hiroshi ^a   Morie, Toshiya ^a   Kato, Shiro ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

(R) 6 aminohexahydro 1,4 diazepine; (S) 2,3 diaminopropyl aminoacetate; DAT 582; Intramolecular reductive cyclization

Indexed keywords

2,3 DIAMINOPROPYLAMINOACETATE; 6 BENZYLOXYCABONYLAMINO 1 METHYL 4 (3 METHYLBENZYL)HEXAHYDRO 1,4 DIAZEPINE; N [1 METHYL 4 (3 METHYLBENZYL)HEXAHYDRO 1,4 DIAZEPIN 6 YL] 1H INDAZOLE 3 CARBOXAMIDE; SEROTONIN 3 ANTAGONIST; UNCLASSIFIED DRUG;

ARTICLE; CHIRALITY; CYCLIZATION; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 0031852052     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.46.1160     Document Type: Article

References (19)

1. Kilpatrick G. J., Bunce K. T., Tyers M. B., Med. Res. Rev., 10, 441-475 (1990).
2. a) Leibundgut U., Lancranjan I., Lancet, 1, 1198 (1987);
3. b) Cunningham D., Pople A., Ford H. T., Hawthorn J., Gazet J. C., Challoner T., ibid., 1, 1461-1462 (1987);
4. c) Andrew P. L. R., Rapeport W. G., Sanger G. J., Trends Pharmacol. Sci., 9, 334-341 (1988).
5. a) Steadman C. J., Talley N. J., Phillips S. F., Mulvihill C., Gastroenierology. 98, A394 (1990);
6. b) Maxton D. G., Haigh C. G., Whorwell P. J., ibid., 100, A468 (1991);
7. c) Prior A., Read N. W., Gut, 31, A1174 (1990);
8. d) Miyata K., Kamato T., Nishida A., Ito H., Yuki H., Yamano M., fsutsumi R., Katsuyama Y., Honda K., J. Pharmacol. Exp. Ther., 261, 297-303 (1992).
9. a) Jones B. J., Costall B., Domeney A. M., Kelly M. E., Naylor R. J., Oakley N. R., Tyers M. B., Br. J. Pharmacol., 93, 985-993 (1988);
10. b) Costall B., Naylor R. J., Tyers M. B., Pharmacol Ther., 47, 181-202 (1990);
11. c) Loisy C., Beorchia S., Centonze V., Fozard J. R., Shechter P. J., Tell G. P., Cephalalgia 5, 79-82 (1985);
12. d) Costall B., Domeney A. M., Kelly M. E., Naylor R. J., Tyers M. B., Br. J. Pharmacol. (Proc. Suppl.), 90, 89P (1987);
13. e) Costall B., Domeney A. M., Naylor R. J., Tyers M. B., Br. J. Pharmacol., 92, 881-894 (1987).
14. Yoshida N., Omoya H., Kato S., Ito T., Eur. J. Pharmacol., 216, 435-440 (1992).
15. Harada H., Morie T., Kato S., J. Chem. Soc., Perkin Trans. 1, 1997, 3219-3225.
16. a) Morie T., Kato S., Harada H., Fujiwara I., Watanabe K., Matsumoto J., J. Chem. Soc., Perkin Trans. 1, 1994, 2565-2569;
17. b) Kato S., Harada H., Morie T., J. Heterocyclic Chem., 32, 637-642 (1995);
18. c) Harada H., Morie T., Hirokawa Y., Kato S., Chem. Pharm. Bull., 44, 2205-2212 (1996).
19. Beaulieu P. L., Schiller P. W., Tetrahedron Lett., 29, 2019-2022 (1988).